NEW ORLEANS — Two substudies from the COAPT trial presented at the American College of Cardiology Scientific Session found that patients with moderate-to-severe or severe aortic regurgitation who had transcatheter mitral valve repair and guideline-directed medical therapy had improvements in health status as soon as 1 month.
However, an echocardiographic substudy was not able to find predictors of improved status beyond right ventricular systolic pressure in patients who had transcatheter mitral valve repair.
As Cardiology Today’s Intervention previously reported, in the main
You may also like
STAT Plus: Pharmalittle: Lawmakers push bill to punish opioid execs; Novartis will have ‘enormous leverage’ pricing its SMA drug
- May 22, 2019
Good morning, everyone, and howRead more